By Drug Target Review2024-12-10T08:00:12
Scientists have decoded the 3D structure of a key enzyme linked to Alzheimer's disease. This breakthrough opens up new possibilities for targeted drug development and better treatment options.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2023-02-13T11:57:11
Sponsored by Agilent
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2025-09-24T14:00:00
Sponsored by Eurofins Discovery
2025-10-22T14:00:00
Sponsored by Wuxi Biologics
2023-05-03T15:39:23
Sponsored by BPS Bioscience
2023-05-10T11:18:16
Sponsored by Revvity
Site powered by Webvision Cloud